4//SEC Filing
Williams Kristen Marie 4
Accession 0001209191-23-038032
CIK 0001396814other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 5:42 PM ET
Size
9.8 KB
Accession
0001209191-23-038032
Insider Transaction Report
Form 4
Williams Kristen Marie
CAO and General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2023-06-14+27,500→ 27,500 totalExercise: $38.74Exp: 2033-06-14→ Common Stock (27,500 underlying) - Award
Common Stock
2023-06-14+10,950→ 31,842 total - Sale
Common Stock
2023-06-14$37.03/sh−6,467$239,473→ 25,375 total
Footnotes (3)
- [F1]Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2024, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F3]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001296965
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 5:42 PM ET
- Size
- 9.8 KB